Total Voting Rights

Summary by AI BETAClose X

Genflow Biosciences plc has announced that as of October 30, 2026, its total issued share capital comprises 594,534,781 ordinary shares, with no shares held in treasury, resulting in a total of 594,534,781 voting rights. This figure serves as the denominator for shareholders to determine their notification obligations under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules regarding their interests in the company's share capital.

Disclaimer*

UK 100

Latest directors dealings